Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey J Langer

Showing results (101-110 of 225) with videos related to

Pageof 23
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 4, 2025
The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR studyChristian Rolfo, David E Gerber, Rupesh Kotecha, et al.
Cancer|May 27, 2015
Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional surveyJoshua M Bauml, Sagar Chokshi, Marilyn M Schapira, et al.
Clinical Lung Cancer|January 30, 2022
Platinum Re-Exposure as a Non-Small Cell Lung Cancer (NSCLC) Treatment Strategy in the Age of ImmunotherapyMelina E Marmarelis, Yu-Xiao Yang, Wei-Ting Hwang, et al.
Cancer Investigation|March 16, 2006
Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancyCorey J Langer, Karen Duffy, Eric M Horwitz, et al.
Plos One|September 29, 2022
A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesotheliomaXiao Wang, Sharyn Katz, John Miura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2010
The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trialsFarzan Siddiqui, Kyounghwa Bae, Corey J Langer, et al.
Clinical Lung Cancer|May 27, 2008
Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?Corey J Langer, Heather Wakelee, Joan Schiller, et al.
Cancers|August 29, 2024
Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line PatientsJeffrey C Thompson, Caitlin Tilsed, Christiana Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2013
Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology surveyRitsuko Komaki, Najma Khalid, Corey J Langer, et al.
Clinical Lung Cancer|November 19, 2013
Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancerGeoffrey A Geiger, Miranda B Kim, Eric P Xanthopoulos, et al.
Pageof 23

Showing results (101-110 of 225) with videos related to

Sort By:
Pageof 23
Lung Cancer (Amsterdam, Netherlands)|November 4, 2025
The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR studyChristian Rolfo, David E Gerber, Rupesh Kotecha, et al.
Cancer|May 27, 2015
Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional surveyJoshua M Bauml, Sagar Chokshi, Marilyn M Schapira, et al.
Clinical Lung Cancer|January 30, 2022
Platinum Re-Exposure as a Non-Small Cell Lung Cancer (NSCLC) Treatment Strategy in the Age of ImmunotherapyMelina E Marmarelis, Yu-Xiao Yang, Wei-Ting Hwang, et al.
Cancer Investigation|March 16, 2006
Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancyCorey J Langer, Karen Duffy, Eric M Horwitz, et al.
Plos One|September 29, 2022
A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesotheliomaXiao Wang, Sharyn Katz, John Miura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2010
The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trialsFarzan Siddiqui, Kyounghwa Bae, Corey J Langer, et al.
Clinical Lung Cancer|May 27, 2008
Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?Corey J Langer, Heather Wakelee, Joan Schiller, et al.
Cancers|August 29, 2024
Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line PatientsJeffrey C Thompson, Caitlin Tilsed, Christiana Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2013
Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology surveyRitsuko Komaki, Najma Khalid, Corey J Langer, et al.
Clinical Lung Cancer|November 19, 2013
Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancerGeoffrey A Geiger, Miranda B Kim, Eric P Xanthopoulos, et al.
Pageof 23